Ocular Therapeutix Insider Sell‑to‑Cover Trades: Market Impact & Outlook
Ocular Therapeutix insider sell‑to‑cover trades: 11,490 shares at $8.54, driven by tax rules, not confidence loss, amid a 25% price drop and negative P/E.
3 minutes to read
Ocular Therapeutix Inc
Ocular Therapeutix CFO Buys 33,000 Stock Options—A Strong Insider Confidence Signal
Ocular Therapeutix CFO Jason Shand buys 33,000 stock options, signalling insider confidence in the company’s growth and potential near‑term upside.
4 minutes to read